Hannah Stirnaman
Nurse Practitioner · Nashville, TNNPI 1982246658
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,224 and has fallen 99.1% since, to $19 in 2024.
Across 136 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$445
- Lilly USA, LLC$180
- AbbVie$173
- Amgen$166
- Pfizer$130
- Merck$126
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,292100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $445 |
| Lilly USA, LLC | 11 | $180 |
| AbbVie | 13 | $173 |
| Amgen | 10 | $166 |
| Pfizer | 8 | $130 |
| Merck | 9 | $126 |
| Boehringer Ingelheim | 7 | $126 |
| AstraZeneca | 9 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $99 |
| Abbott | 4 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $77 |
| GSK | 6 | $72 |
| Biohaven Pharmaceuticals, Inc. | 3 | $69 |
| Viiv Healthcare Company | 3 | $59 |
| Sanofi-aventis U.S. LLC | 4 | $53 |
| Alkermes, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Dexcom, Inc. | 2 | $38 |
| Johnson & Johnson | 2 | $33 |
| Bayer | 2 | $31 |
| Eisai Inc. | 2 | $28 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
How this compares
$2,292 in reported general payments places this provider in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 13 | $161 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Nashville
- Susan UtleyNashville$194K
- Brooke FaughtNashville$87K
- Lauren WelchNashville$71K
- Patricia MorrisNashville$53K
- Molly MueckeNashville$30K
- Cherish HoltNashville$20K
- Virginia BradshawNashville$17K
- Bettina EnghNashville$17K
- Megan HuningNashville$12K
- Amy HatcherMurfreesboro$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.